1. Access Data. OZEMPIC (semaglutide) injection, for subcutaneous use. 2017. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209637lbl.pdf.
5. Semaglutide (rx): Pharmacology. Medscape. 2023. https://reference.medscape.com/drug/ozempic-rybelsus-wegovy-semaglutide-1000174#10.
6. Ikushima I, Jensen L, et al. A Randomized Trial Investigating the Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Semaglutide Once-Weekly in Healthy Male Japanese and Caucasian Subjects. Adv Ther. 2018;35(4):531-44.
9. Costello. LCRA. Glucagon-like Peptide-1 Receptor Agonists: StatPearls Publishing; 2023. https://www.ncbi.nlm.nih.gov/books/NBK551568/
10. Shaefer CF. Kushner P. Aguilar R. User's guide to mechanism of action and clinical use of GLP-1 receptor agonists. Postgrad Med. 2015;127(8):818-26.
11. TAG. RYBELSUS (semaglutide) tablets, for oral use. 2017.